Also from this source


24 Apr, 2017, 08:15 ET Immune Receives Nasdaq Letter

You just read:

Immune Pharmaceuticals Will Request an Appeal to Regain Compliance with Nasdaq's Minimum Bid Price Rule

News provided by

Immune Pharmaceuticals Inc.

09 Jan, 2017, 18:11 ET